Peyote and mescaline exposures: A 12-year review of a statewide poison center database

Clinical Toxicology

Volumn 48, Issue 4, 2010, Pages 350-353

  Carstairs, Shaun D ^a,b   Cantrell, F Lee ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c California Poison Control System   (United States)

Author keywords

Acute poisoning; Hallucinations; Poison control centers; Toxic plants

Indexed keywords

ACTIVATED CARBON; BENZODIAZEPINE DERIVATIVE; DROPERIDOL; INFUSION FLUID; MESCALINE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; CLINICAL ARTICLE; DATA BASE; DRUG EXPOSURE; DRUG INTOXICATION; ENDOTRACHEAL INTUBATION; FEMALE; HALLUCINATION; HEALTH CARE FACILITY; HEART RATE; HOSPITALIZATION; HUMAN; MALE; MYDRIASIS; NYSTAGMUS; OUTCOME ASSESSMENT; TACHYCARDIA; VOMITING;

ADOLESCENT; ADULT; DATABASES, FACTUAL; FEMALE; HALLUCINOGENS; HUMANS; MALE; MESCALINE; MIDDLE AGED; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

CACTACEAE; LOPHOPHORA WILLIAMSII;

EID: 77952896688     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650903586745     Document Type: Article

References (13)

1. McLaughlin JL. Peyote: an introduction. Lloydia 1973; 36:1-8.
2. Erowid Peyote (Lophophora williamsii) Vault. Available at: http:// www.erowid.org/plants/peyote/peyote.shtml. Accessed 27 October 2009.
3. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2007 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th annual report. Clin Toxicol (Phila) 2008; 46:927-1057.
4. Lumholtz C. Unknown Mexico. London: MacMillan and Co., Limited; 1903:356-379.
5. Schultes RE. The appeal of peyote (Lophophora williamsii) as a medicine. Am Anthropol 1938; 40:698-715.
6. US Code: Title 42, 1996a. Traditional Indian religious use of peyote. Available at: http://www.law.cornell.edu/uscode/search/display.html?terms= 1996a&url=/uscode/html/uscode42/usc-sec-42-00001996-a000-.html. Accessed 27 October 2009.
7. Bergman RL. Navajo peyote use: its apparent safety. Am J Psychiatry 1971; 128:695-699.
8. Nolte KB, Zumwalt RE. Fatal peyote ingestion associated with Mallory-Weiss lacerations. West J Med 1999; 170:328.
9. Hashimoto H, Clyde VJ, Parko KL. Botulism from peyote. N Engl J Med 1998; 339:203-204.
10. Shulgin AT. Mescaline: the chemistry and pharmacology of its analogs. Lloydia 1973; 36:46-58.
11. Aboul-Enein HY. Mescaline: a pharmacological profile. Am J Pharm Sci Support Public Health 1973; 145:125-128.
12. The NHSDA Report: Racial and Ethnic Differences in Youth Hallucinogen Use. Available at: http://www.oas.samhsa.gov/2k3/youth Hallucinogens/ youthHallucinogens.pdf. Accessed 18 December 2009.
13. Hermle L, Fünfgeld M, Oepen G, Botsch H, Borchardt D, Gouzoulis E, Fehrenbach RA, Spitzer M. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research. Biol Psychiatry 1992; 32:976-991.